#Barcelona #IBS #UEG Week #Antibiotic Use

New Study Reveals Link Between Childhood Antibiotic Use and IBS Risk

A recent study unveiled at UEG Week 2026 underlines a significant correlation between early antibiotic consumption and an increased risk of developing irritable bowel syndrome (IBS) later in life. Analyzing data from the Swedish BAMSE birth cohort, consisting of 2,853 participants, the research suggests that the odds of IBS at the age of 24 are notably higher in individuals who received antibiotics during their childhood and adolescence.

The findings indicate that approximately 10% of the participants reported having IBS by the time they reached 24. Notably, a stark contrast was observed in antibiotic prescription histories between those with and without IBS. A substantial 87.8% of participants diagnosed with IBS had received antibiotics, compared to only 80.2% among those who were symptom-free. This suggests that antibiotic use in early life could be a contributing factor to gastrointestinal disorders.

Study Details

The research scrutinized antibiotic prescription records from the Swedish Prescribed Drug Register, focusing on individuals from the ages of 9 to 11 until just before their IBS diagnosis at age 24. The results illustrated that the likelihood of developing IBS increased in tandem with the number of antibiotic prescriptions received. Specifically, participants who were prescribed one or two courses of antibiotics exhibited a 1.3 times greater chance of developing IBS, while those who had received three to five courses demonstrated a 1.6 times increase. Alarmingly, individuals who were prescribed six or more courses had a staggering 1.7 times higher probability of developing IBS compared to those who received no antibiotics.

The analysis went further, evaluating specific classes of antibiotics. Notably, tetracyclines and cephalosporins showed a significant association with IBS risk. Any prescription of tetracyclines was linked to a 1.4-fold increase in IBS odds, while three or more prescriptions of cephalosporins correlated with a 6.0-fold increase.

Implications of the Findings

These findings prompt crucial considerations regarding antibiotic use, particularly in pediatric populations. Dr. Jessica Sjölund, the lead author of the study, emphasized the need for a balanced approach to antibiotic prescribing. While antibiotics are essential for treating bacterial infections, their repeated and possibly unnecessary use may have long-term gastrointestinal consequences. Dr. Sjölund highlights the potential changes to the gut microbiome as a possible explanation for the observed association, citing previous studies showing how antibiotics can disrupt microbial balance, potentially leading to conditions like IBS.

Dr. Sjölund advises healthcare professionals to weigh the benefits of antibiotic treatment against the risks of long-term side effects. "Our findings should not deter the necessary use of antibiotics but rather underscore the importance of cautious prescribing practices to minimize potential adverse outcomes for patients,